My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
C
>
CHARTER
>
1245
>
2900 - Site Mitigation Program
>
PR0542201
>
COMPLIANCE INFO
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/1/2021 4:35:41 PM
Creation date
6/1/2021 4:13:37 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
COMPLIANCE INFO
RECORD_ID
PR0542201
PE
2960
FACILITY_ID
FA0024238
FACILITY_NAME
JM EQUIPMENT COMPANY
STREET_NUMBER
1245
Direction
W
STREET_NAME
CHARTER
STREET_TYPE
WAY
City
STOCKTON
Zip
95206
APN
16323034
CURRENT_STATUS
01
SITE_LOCATION
1245 W CHARTER WAY
P_LOCATION
01
QC Status
Approved
Scanner
SJGOV\dsedra
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
213
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
ADVISORY - ACTIVE SOIL GAS INVESTIGATIONS <br />Carbon disulfide <br />2-Hexanone <br />Styrene <br />Methyl ethyl ketone <br />Methyl isobutyl ketone <br />Ethylene dibromide <br />1,4-Dioxane <br />6.2 REPORTING LIMITS FOR TARGET COMPOUNDS <br />Reporting limits (RLs) should be based on the DQ0s of the investigation. <br />Corresponding analytical methods should be selected to achieve RLs that are below <br />regulatory or risk-based screening levels. The RLs for the leak check compound should <br />be reported at the RL of the target analytes. <br />When RLs are elevated due to sample dilution, the laboratory should provide a written <br />explanation of why the project-specific RLs were not achieved. In some instances, <br />sample dilution is necessary because of high concentrations of non-target compounds <br />(background). It may be necessary to collect new samples for reanalysis to achieve <br />appropriate RLs pursuant to the project's DQ0s. A higher RL as a result of sample <br />dilution is acceptable for the compound(s) whose concentration in an undiluted sample <br />exceeds the upper level of an initial calibration range. Non-detected results for all target <br />compounds shall be reported at the lowest dilution(s) concentration or no dilution <br />concentration. <br />6.3 QUALITY ASSURANCE/QUALITY CONTROL <br />This section primarily focuses on field laboratory QA/QC and not stationary laboratory <br />QA/QC. For a detailed discussion on stationary laboratory QA/QC, refer to Appendix F. <br />Laboratories should comply with the project QAPP, USEPA Methods, and the criteria in <br />this Advisory. The analytical data should be consistent with the DQ0s established for the <br />project. <br />The regulating agency may inspect the field and/or stationary laboratory QA/QC <br />procedures. Copies of the QA/QC plan and laboratory calibration data should be <br />presented upon request. <br />All calibration and QA/QC standards, traceable to a source, should be documented by <br />the laboratory. Continuing calibration and QC standards should be from a second <br />source or a different lot from the same supplier. Vapor phase standards should be used <br />to calibrate laboratory instruments. <br />The following items should be included when using USEPA Methods: <br />Initial calibration; <br />Daily calibration/continuing calibration; <br />Laboratory control spike; <br />Internal standards; <br />July 2015 32
The URL can be used to link to this page
Your browser does not support the video tag.